WST - West Pharmaceutical Services, Inc.

NYSE - NYSE Delayed Price. Currency in USD

West Pharmaceutical Services, Inc.

530 Herman O. West Drive
Exton, PA 19341
United States

Sector : Healthcare
Industry : Medical Instruments & Supplies
Full Time Employees : 7,600

Key Executives

Name Title Pay Exercised Year Born
Mr. Eric M. Green CEO, Pres & Director 1.63M N/A 1970
Mr. David A. Montecalvo Sr. VP and Chief Operations & Supply Chain Officer 684.77k N/A 1965
Mr. George Lloyd Miller Sr. VP, Gen. Counsel & Corp. Sec. 663.88k N/A 1955
Ms. Karen A. Flynn Chief Commercial Officer & Sr. VP 789.83k N/A 1963
Mr. Bernard J. Birkett Sr. VP, CFO & Treasurer N/A N/A 1969
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including CZ, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated services, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was founded in 1923 and is headquartered in Exton, Pennsylvania.

Corporate Governance

West Pharmaceutical Services, Inc.’s ISS Governance QualityScore as of July 29, 2019 is 2. The pillar scores are Audit: 2; Board: 1; Shareholder Rights: 3; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS) . Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.